DK630088D0 - AZELASTINEMBONATE, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS COMPOUND AS ACTIVE AGENT - Google Patents

AZELASTINEMBONATE, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS COMPOUND AS ACTIVE AGENT

Info

Publication number
DK630088D0
DK630088D0 DK630088A DK630088A DK630088D0 DK 630088 D0 DK630088 D0 DK 630088D0 DK 630088 A DK630088 A DK 630088A DK 630088 A DK630088 A DK 630088A DK 630088 D0 DK630088 D0 DK 630088D0
Authority
DK
Denmark
Prior art keywords
azelastinembonate
procedures
preparing
compound
active agent
Prior art date
Application number
DK630088A
Other languages
Danish (da)
Other versions
DK170339B1 (en
DK630088A (en
Inventor
Gerhard Scheffler
Dieter Sauerbier
Juergen Engel
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of DK630088D0 publication Critical patent/DK630088D0/en
Publication of DK630088A publication Critical patent/DK630088A/en
Application granted granted Critical
Publication of DK170339B1 publication Critical patent/DK170339B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Azelastine embonate and pharmaceutical compositions which contain azelastine embonate as the active ingredient.
DK630088A 1987-11-13 1988-11-11 Azelastine Embonate, Method of Preparation, Preparations Containing, and Stable, Aqueous Suspensions of this Compound, and Use of Azelastine Embonate in the Preparation of Medicines DK170339B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3738641 1987-11-13
DE3738641 1987-11-13
SG153894A SG153894G (en) 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
SG153894 1994-10-21

Publications (3)

Publication Number Publication Date
DK630088D0 true DK630088D0 (en) 1988-11-11
DK630088A DK630088A (en) 1989-05-14
DK170339B1 DK170339B1 (en) 1995-08-07

Family

ID=25861795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK630088A DK170339B1 (en) 1987-11-13 1988-11-11 Azelastine Embonate, Method of Preparation, Preparations Containing, and Stable, Aqueous Suspensions of this Compound, and Use of Azelastine Embonate in the Preparation of Medicines

Country Status (9)

Country Link
EP (1) EP0316639B1 (en)
JP (1) JP2730581B2 (en)
AT (1) ATE106883T1 (en)
CA (1) CA1317595C (en)
DE (1) DE3850044D1 (en)
DK (1) DK170339B1 (en)
ES (1) ES2053679T3 (en)
HK (1) HK135494A (en)
SG (1) SG153894G (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4013696A1 (en) * 1989-05-05 1990-11-08 Asta Pharma Ag New azelastin salts
JPH04198180A (en) * 1990-11-28 1992-07-17 Eezai Kagaku Kk Production of benzylphthalazone derivative
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
KR20070104884A (en) 2004-11-24 2007-10-29 메드포인트 헬쓰케어 인크. Compositions comprising azelastine and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH572914A5 (en) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab

Also Published As

Publication number Publication date
EP0316639A3 (en) 1990-07-18
EP0316639A2 (en) 1989-05-24
HK135494A (en) 1994-12-09
EP0316639B1 (en) 1994-06-08
DK170339B1 (en) 1995-08-07
JPH01153686A (en) 1989-06-15
ES2053679T3 (en) 1994-08-01
DE3850044D1 (en) 1994-07-14
SG153894G (en) 1995-03-17
JP2730581B2 (en) 1998-03-25
ATE106883T1 (en) 1994-06-15
CA1317595C (en) 1993-05-11
DK630088A (en) 1989-05-14

Similar Documents

Publication Publication Date Title
DK0548114T5 (en) Mometasone furoate monohydrate, process for its preparation and pharmaceutical preparations containing this
PT750618E (en) OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ATE216590T1 (en) DRUG FORMULATIONS FOR IL-12
PT83872A (en) DRUG
DK0513543T3 (en) Amidinophenylalanine derivatives, processes for their preparation, their use and anticoagulants containing them
DK0530087T3 (en) New Naphthylethylurea and Naphthylethylthiourea Compounds, Methods of Preparation and Pharmaceutical Agents Containing Them
DK254787A (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISEASES CAUSED BY OXIDATIVE STRESS AND CONTAINING 2-PHENYL.1,2-BENZISO-SELENAZOL-3 (2H) -ON AS ACTIVE INGREDIENT
DK605786A (en) STABILIZED HUMAN TISSUE PLASMINOGEN ACTIVATOR PREPARATIONS
ES2134801T3 (en) CRYSTAL TIAGABINE HYDROCHLORIDE MONOHYDRATE, ITS PREPARATION AND USE.
DK0508220T3 (en) Amidinophenylalanine derivatives, processes for their preparation, their use and their contents
DK127588D0 (en) BETA-AMINOETHYL-SUBSTITUTED PHENYL COMPOUNDS, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND PROCEDURES FOR THE PREPARATION OF SUCH COMPOUNDS
DK122191A (en) BENZIMIDAZOLD DERIVATIVES AND PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF, AND PROCEDURES FOR THE PREPARATION OF SAME
DK630088D0 (en) AZELASTINEMBONATE, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS COMPOUND AS ACTIVE AGENT
NO883047L (en) SUBSTITUTED BENZIMIDAZOLES, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEIR USE.
IL99471A0 (en) Pharmaceutical compositions containing pyridylmethylsulphinyl-1h-benzimidazole derivatives as active ingredient therein
FI884545A0 (en) PHARMACEUTICAL COMPOSITION, SOM INNEHAOLLER AVSVAELLANDE PIPERIDINOALKANOLFOERENINGAR.
DK88087D0 (en) TRICYCLIC 5- (3-CHLOR-6-METHYL-5,5-DIOXO-6,11-DIHYDRO-DIBENZO- (C, F) - (1,2) -THIAZEPIN-11-YL) -AMINO-PENTANIC ACID DERIVATIVE, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
DK524489A (en) PROCEDURE FOR THE PREPARATION OF BIOLOGICAL ACTIVE COMPOUNDS, SPECIAL ENZYMER
DK4287D0 (en) POLYFLUORAL CHYLTHIOMETHYL COMPOUNDS, PROCEDURES FOR PREPARING THEM AND USING SUCH COMPOUNDS AS SURFACTIVE AGENTS
NO882030D0 (en) PROCEDURE FOR THE PREPARATION OF HYDRAININE DERIVATIVES FOR USE AS ANTIHYPERTENSIVE AGENT.
DK34888D0 (en) PROCEDURE FOR THE PREPARATION OF N, N- (DIBENZOEXATRIENYLEN)
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
IT8219652A0 (en) PROPIONYLGLYCINE DERIVATIVE, PROCESSES FOR ITS PREPARATION AND THERAPEUTIC COMPOSITIONS WHICH CONTAIN IT AS THE ACTIVE INGREDIENT.
SE8503513L (en) PHARMACEUTICAL AND COSMETIC COMPOSITIONS WHICH ACTIVE INGREDIENT INCLUDE ACETYL-10-TRIACETOXI-1,8,9-ANTRACEN
DK164317C (en) QUINOXALIN-2,3-DION COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE COMPOUNDS

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired